Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and [...]
Canada's COVID-19 Immunity Task Force (CITF) announces its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease. This $4 million investment will be carried out by the Canadian Longitudinal Study on Aging (CLSA), a national platform for research [...]
This study will analyze blood samples collected for standard testing in pregnancy from expectant women across Canada to help determine the spread of SARS-CoV-2 and when the virus entered Canada Today, Canada's COVID-19 Immunity Task Force (CITF) announces its support for a study of antenatal serum samples (using blood samples from standard tests from expectant women). This $3.1 [...]